Results

Total Results: 6,972 records

Showing results for "medications".
Users also searched for: medication reconciliation

361. ADHD: Available Information on Impact and Gaps/Variations in Care (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-2.pdf
     November 12, 2010 - ADHD medications can reduce symptoms, but might be associated with side effects and symptoms effecting … Prescribing habits:  The use of stimulant medications in the United States has risen and as a result … there is concern over the potential for over diagnosis of ADHD and the potential for overuse of medications … A study by Sheffler et al reveal that the United States is the world’s largest consumer of ADHD medications … The Global Market for ADHD Medications 3) Visser M S, Bitsko R H, Danielson M L, et al.

362. 1b.3_ICD_and_CPT_Codes_508 (xls file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/ICD-and-CPT-codes.xlsx
     January 01, 2018 - Room ED Visits Revenue 0981 Professional Fees (096x) Emergency Room End of Table Medications_508 Medications … Notes Note Description Data source for prescriptions for asthma related medications Use NCQA NDC list … Note: For 2018 data, the files include more than asthma medications, so will need to filter first on … Medications for eligibility Asthma-related medicine refers to long-acting beta-agonist (alone or in combination … Eliminate medications in the following 2 categories: leukotriene modifiers, short-acting inhaled beta

363. Addressing Questions Asked by Staff: Nasal Iodophor for MRSA Carriers With Devices (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/hai/abate/faqs/faq-iodophor.pdf
     March 01, 2022 - What if my patient has been prescribed other nasal medications? … If possible, separate the provision of those medications from nasal iodophor application by several … physician, who will determine all necessary actions related to discontinuing the product and ordering any medications … What if my patient has been prescribed other nasal medications?

364. Addressing Questions Asked by Staff: Nasal Mupirocin for MRSA Carriers With Devices (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/hai/abate/faqs/faq-mupirocin.pdf
     March 01, 2022 - What if my patients have been prescribed other nasal medications? … If possible, separate the provision of those medications from nasal mupirocin application by several … physician, who will decide all necessary actions related to discontinuing product and ordering any medications … What if my patients have been prescribed other nasal medications?

365. Using Comparative Effectiveness Reviews to Optimize Quality of Life for Persons with Diabetes and Chronic Pain (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/iadapt/safford.pdf
     December 17, 2014 - Effectiveness Reviews to Optimize Quality of Life for Persons with Diabetes and Chronic Pain Description Medications … diabetes; however, cognitive-behavioral therapy (CBT) can improve functioning and reduce reliance on medications

366. Table 6: Categories of Medication Error Classification | Agency for Healthcare Research and Quality
     www.ahrq.gov/es/patient-safety/settings/hospital/match/table-6.html
     August 01, 2012 - Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation Table … : Categories of Medication Error Classification Previous Page   Table of Contents Medications

367. Table 6: Categories of Medication Error Classification | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/match/table-6.html
     August 01, 2012 - Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation Table … : Categories of Medication Error Classification Previous Page   Table of Contents Medications

368. Emergency Visits for Opioid Use Rose White Treatment for Illicit Drug Use Remained Unchanged (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/qdr-data-spotlight-opioids-edvisits-tx.pdf
     August 11, 2021 - also makes up the highest percentage of drug overdose deaths in the United States.3 Treatment with medications … #medications-used-in-mat https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions … The medications (buprenorphine, buprenorphine/naloxone and/ or naltrexone) are available for treatment … Addressing racial and ethnic disparities in the use of medications for opioid use disorder. … American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications

369. Strategy 4: IDEA Discharge Planning (Tool 3) (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/engagingfamilies/strategy4/Strat4_Tool_3_Physician_HO_508.docx
     January 01, 2010 - Changes or discrepancies in medications before and after discharge[endnoteRef:3],[endnoteRef:4] [3: … Inadequate preparation for patient and family related to medications, danger signs, or lifestyle changes3,4 … Review medications 3. Highlight warning signs and problems 4. Explain test results 5.

370. RED Lowering Hospital Readmissions and Improving Patient Satisfaction at Euclid Hospital in Ohio | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsroom/case-studies/201415.html
     September 01, 2014 - By designating discharge advocates who help patients understand their medications and schedule follow-up … appointed as a care advocate sees heart failure patients by the second day of their inpatient stay, reviews medications … , helps patients understand their medication routine, and ensures they can afford their medications or

371. Use of Multiple Concurrent Antipsychotics in Children (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
     May 01, 2018 - longer than 90 days during the measurement year who were on two or more concurrent antipsychotic medications … Numerator Statement Those on two or more concurrent antipsychotic medications for at least 90 days during … This measure was developed as part of a set of measures to assess the use of antipsychotic medications … These risks are in addition to the side effects of antipsychotic medications that include metabolic … Stimulant and atypical antipsychotic medications for children placed in foster homes.

372. Resources for Shared Decision Making | Agency for Healthcare Research and Quality
     www.ahrq.gov/sdm/resources/index.html
     May 01, 2023 - Disorder –a decision aid on medication-assisted Treatment (MAT) Considering the Role of Antipsychotic Medications … in My Recovery Plan –a decision aid on antipsychotic medications

373. Automated Outreach & Adherence to Cholesterol-Lowering Medication | Agency for Healthcare Research and Quality
     www.ahrq.gov/evidencenow/heart-health/cholesterol/outreach.html
     September 01, 2018 - Medication Resource title: Automated Outreach to Increase Primary Adherence to Cholesterol-Lowering Medications

374. 47. 10 Key Guideline Recommendations (Number 3) | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-overview/slide47.html
     October 01, 2014 - should encourage every patient willing to make a quit attempt to use the counseling treatments and medications

375. Safemed Facguide (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.docx
     May 01, 2017 - Administration SAY: The Safe Medication Administration bundle provides information on high-alert medications … Slide 1 SAY: In this module, we will do the following: · Define high-alert medications. · Identify … These key safety elements can also be adapted and applied to other high-alert medications used in L&D … Slide 3 SAY: High-alert medications are defined by the Institute for Safe Medication Practices as … Limiting access to these medications. Using auxiliary labels and automated alerts.

376. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
     January 01, 2009 - AHRQ).iv This review addressed a number of key questions for the committee, including the efficacy of medications … have been raised about the rare occurrence of sudden cardiac death among children using stimulant medications … Other considerations in the recommendation about treating children 4-6 years of age with stimulant medications … Thus, prior to initiating medications, the physician should assess the severity of the child’s ADHD. … Sudden death and use of stimulant medications in youths.

377. Appendix C9: Fall Interventions Monitor Sample | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/long-term-care/resource/injuries/fallspx/apcfigtxt9.html
     December 01, 2017 - Date: 4/19/04   Date: 4/19/04 Medications Are interventions effective: _X_ Yes ___ No … Agitation decreased Medications Are interventions effective: ___ Yes _X_ No Changes: Comments

378. Appendix, Questions to Ask When Developing Your Design Team and Rationale | Agency for Healthcare Research and Quality
     www.ahrq.gov/es/patient-safety/settings/hospital/match/appendix/app-1.html
     July 01, 2022 - Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation Appendix … Developing Your Design Team and Rationale Previous Page Next Page Table of Contents Medications

379. Appendix, Questions to Ask When Developing Your Design Team and Rationale | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/match/appendix/app-1.html
     July 01, 2022 - Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation Appendix … Developing Your Design Team and Rationale Previous Page Next Page Table of Contents Medications

380. 20. Varenicline | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-overview/slide20.html
     October 01, 2014 - Effectiveness and abstinence rates for various medications and medication combinations compared to placebo